fda compounding semaglutide crackdown news today 2025 The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded (Wegovy) weight-loss pill from the FDA crackdown on off-brand Ozempic

The TRIUMPH-4 trial confirmed 28.7% weight loss in adults with obesity and knee osteoarthritis

But both can be prescribed for other off-label uses

One of the great things about fillers is that they can benefit you at any point in your weight loss journey

Saving Money or Managing Supply Gaps Microdosing first emerged as a strategy to cope with the past Ozempic and Wegovy shortages

They can often track your luggage and have it delivered as soon as possible

As new approved indications for GLP-1s continue to emerge, including uses related to cardiovascular disease and obstructive sleep apnea, more patients qualify for the medication